HAS2 and glioblastoma: This is consistent with the findings of Yoo et al. [27] and others, who reported that the recurrence of GBM after radiation therapy is attributed to the increase of HAS2 induced by radiation, which increases the production of HA and subsequently activates carcinogenic signaling pathways.